Peer-reviewed veterinary case report
RXR-LXR heterodimer modulators for the potential treatment of dyslipidemia.
- Journal:
- Bioorganic & medicinal chemistry letters
- Year:
- 2007
- Authors:
- Lagu, Bharat et al.
- Affiliation:
- Johnson and Johnson Pharmaceutical Research and Development · United States
Abstract
A number of RXR agonists were synthesized and screened in functional assays. The synthesis and the structure-activity relationship (SAR) within the series of compounds will be presented. Some in vivo data in rodent models for dyslipidemia and diabetes will also be presented.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/17485209/